{"id":"https://openalex.org/W2010648577","doi":"https://doi.org/10.1038/clpt.1989.199","title":"Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease","display_name":"Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease","alternate_titles":[],"publication_year":1989,"publication_date":"1989-12-01","ids":{"openalex":"https://openalex.org/W2010648577","doi":"https://doi.org/10.1038/clpt.1989.199","mag":"2010648577","pmid":"https://pubmed.ncbi.nlm.nih.gov/2598567"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.1989.199","doi":"https://doi.org/10.1038/clpt.1989.199","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.1989.199","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010648577"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113934812","display_name":"Duncan R. Forsyth","orcid":"https://orcid.org/0009-0005-2980-6061","observed_orcids":["https://orcid.org/0009-0005-2980-6061"]},"institutions":[{"id":"https://openalex.org/I2800201669","display_name":"Frenchay Hospital","ror":"https://ror.org/03z8x2j90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201669","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Duncan R Forsyth","raw_affiliation_strings":["University Department of Medicine, Bristol Royal Infirmary, England","University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Medicine, Bristol Royal Infirmary, England","institution_ids":["https://openalex.org/I2802901496"]},{"raw_affiliation_string":"University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital","institution_ids":["https://openalex.org/I2800201669","https://openalex.org/I2802901496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006644613","display_name":"Gordon K Wilcock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800201669","display_name":"Frenchay Hospital","ror":"https://ror.org/03z8x2j90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201669","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gordon K Wilcock","raw_affiliation_strings":["University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital","institution_ids":["https://openalex.org/I2800201669","https://openalex.org/I2802901496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036979004","display_name":"Robert Morgan","orcid":"https://orcid.org/0000-0002-8108-5258","observed_orcids":["https://orcid.org/0000-0002-8108-5258"]},"institutions":[{"id":"https://openalex.org/I2800201669","display_name":"Frenchay Hospital","ror":"https://ror.org/03z8x2j90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201669","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert A Morgan","raw_affiliation_strings":["University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital","institution_ids":["https://openalex.org/I2800201669","https://openalex.org/I2802901496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111636588","display_name":"Carol Truman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800201669","display_name":"Frenchay Hospital","ror":"https://ror.org/03z8x2j90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201669","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carol A Truman","raw_affiliation_strings":["University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital","institution_ids":["https://openalex.org/I2800201669","https://openalex.org/I2802901496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111855132","display_name":"Julia M. Ford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800201669","display_name":"Frenchay Hospital","ror":"https://ror.org/03z8x2j90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201669","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julia M Ford","raw_affiliation_strings":["University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital","institution_ids":["https://openalex.org/I2800201669","https://openalex.org/I2802901496"]}]},{"author_position":"last","author":{"id":null,"display_name":"Clive J C Roberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800201669","display_name":"Frenchay Hospital","ror":"https://ror.org/03z8x2j90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201669","https://openalex.org/I4405276282"]},{"id":"https://openalex.org/I2802901496","display_name":"Bristol Royal Infirmary","ror":"https://ror.org/031p4kj21","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802901496","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Clive J C Roberts","raw_affiliation_strings":["University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Medicine, Bristol Royal Infirmary Department of Care of the Elderly, Frenchay Hospital","institution_ids":["https://openalex.org/I2800201669","https://openalex.org/I2802901496"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2800201669","https://openalex.org/I2802901496"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":5.6038,"has_fulltext":false,"cited_by_count":59,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96444706,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"46","issue":"6","first_page":"634","last_page":"641"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9079999923706055},{"id":"https://openalex.org/keywords/circulating-half-life","display_name":"serum half-life","score":0.8930000066757202},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.7269999980926514},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9559999704360962},{"id":"https://openalex.org/keywords/first-pass-metabolism","display_name":"first-pass metabolism","score":0.9300000071525574},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.9049999713897705},{"id":"https://openalex.org/keywords/drug-metabolites","display_name":"drug metabolites","score":0.7009999752044678},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.7149999737739563},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C2779046751","wikidata":"https://www.wikidata.org/wiki/Q421076","display_name":"Tacrine","level":4,"score":0.9846158623695374},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.617131233215332},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5039400458335876},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.5006248950958252},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4992060661315918},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3486135005950928},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.20843970775604248},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19200986623764038},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.04694849252700806},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.04616013169288635},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000609","descriptor_name":"Aminoacridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001919","descriptor_name":"Bradycardia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013619","descriptor_name":"Tacrine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016018","descriptor_name":"Least-Squares Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/clpt.1989.199","doi":"https://doi.org/10.1038/clpt.1989.199","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.1989.199","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:2598567","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2598567","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1968627689","https://openalex.org/W1972300483","https://openalex.org/W1974639262","https://openalex.org/W2010120109","https://openalex.org/W2019240871","https://openalex.org/W2021280501","https://openalex.org/W2104227586","https://openalex.org/W2110765139","https://openalex.org/W2156220037","https://openalex.org/W2168210393","https://openalex.org/W2220578746","https://openalex.org/W2344563485"],"related_works":["https://openalex.org/W2062965366","https://openalex.org/W1997565819","https://openalex.org/W1529683943","https://openalex.org/W2047464738","https://openalex.org/W2051398024","https://openalex.org/W2438058786","https://openalex.org/W2147879518","https://openalex.org/W2012201011","https://openalex.org/W2312475674","https://openalex.org/W2026296435"],"abstract_inverted_index":{"The":[0,85,146],"clinical":[1],"pharmacokinetics":[2],"of":[3,17,21,51,65,76,143,149],"tacrine":[4,150],"hydrochloride":[5,151],"have":[6,12],"been":[7],"characterized":[8],"in":[9,27,36,45,55,74,126],"patients":[10,29,38,47,57,78],"who":[11,79],"Alzheimer's":[13],"disease.":[14],"Serum":[15],"concentrations":[16],"the":[18,77,97,106,144],"drug":[19,66],"and":[20,54,67,110,129],"its":[22],"probable":[23],"metabolite":[24,68],"were":[25],"monitored":[26],"eight":[28],"after":[30,39,48,58,96,105,115],"a":[31,40,59,81],"25":[32,98],"mg":[33,42,99,108],"oral":[34,43,130],"dose,":[35,44,100,109],"six":[37],"50":[41,52,107],"four":[46],"repeated":[49],"administration":[50],"mg,":[53],"two":[56],"small":[60,82],"intravenous":[61,83,119],"dose.":[62,84,145],"Urinary":[63],"excretion":[64],"for":[69],"24":[70],"hours":[71,92,104,114],"was":[72,88,122,132,139],"measured":[73],"one":[75],"received":[80],"serum":[86],"half-life":[87],"1.59":[89],"+/-":[90,94,102,112],"0.15":[91],"(mean":[93],"SEM)":[95],"2.14":[101],"0.24":[103],"2.91":[111],"0.39":[113],"continuous":[116],"treatment.":[117],"After":[118],"administration,":[120],"clearance":[121],"above":[123],"600":[124],"ml/min":[125],"both":[127],"patients,":[128],"bioavailability":[131,148],"calculated":[133],"at":[134],"below":[135],"5%.":[136],"Urine":[137],"recovery":[138],"less":[140],"than":[141],"3%":[142],"low":[147],"is":[152],"partly":[153],"explained":[154],"by":[155],"presystemic":[156],"metabolism.":[157]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2010648577","counts_by_year":[{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
